Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients

This study was undertaken to evaluate the effect of oral administration of lactoferrin (LF) and lactoperoxidase-(LPO-)containing tablet on periodontal condition. Seventy-two individuals with chronic periodontitis were randomly assigned to take either bovine LF and LPO-containing tablets (test group,...

Full description

Saved in:
Bibliographic Details
Main Authors: Eiju Shimizu, Tetsuo Kobayashi, Hiroyuki Wakabayashi, Koji Yamauchi, Keiji Iwatsuki, Hiromasa Yoshie
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Dentistry
Online Access:http://dx.doi.org/10.1155/2011/405139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568213211185152
author Eiju Shimizu
Tetsuo Kobayashi
Hiroyuki Wakabayashi
Koji Yamauchi
Keiji Iwatsuki
Hiromasa Yoshie
author_facet Eiju Shimizu
Tetsuo Kobayashi
Hiroyuki Wakabayashi
Koji Yamauchi
Keiji Iwatsuki
Hiromasa Yoshie
author_sort Eiju Shimizu
collection DOAJ
description This study was undertaken to evaluate the effect of oral administration of lactoferrin (LF) and lactoperoxidase-(LPO-)containing tablet on periodontal condition. Seventy-two individuals with chronic periodontitis were randomly assigned to take either bovine LF and LPO-containing tablets (test group, n=37) or control tablets (control group, n=35) every day for 12 weeks. Periodontal parameters and levels of subgingival plaque bacteria, human and bovine LF, and endotoxin in gingival crevicular fluid (GCF) were evaluated at baseline, 1 week, 4 weeks, and 12 weeks. Significant differences were observed in GCF levels of bovine LF between the test and control groups throughout the study (P<.05). However, clinical and bacteriological parameter values proved comparable between the two groups at 1 week to 12 weeks. Therefore, the effect of oral administration of LF and LPO-containing tablets might be weak on periodontal and bacteriological profile in this study.
format Article
id doaj-art-51a11137341d42e8ba0936458b75d5b5
institution Kabale University
issn 1687-8728
1687-8736
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Dentistry
spelling doaj-art-51a11137341d42e8ba0936458b75d5b52025-02-03T00:59:33ZengWileyInternational Journal of Dentistry1687-87281687-87362011-01-01201110.1155/2011/405139405139Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis PatientsEiju Shimizu0Tetsuo Kobayashi1Hiroyuki Wakabayashi2Koji Yamauchi3Keiji Iwatsuki4Hiromasa Yoshie5Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanDivision of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanFood Science & Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, JapanFood Science & Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, JapanFood Science & Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, JapanDivision of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanThis study was undertaken to evaluate the effect of oral administration of lactoferrin (LF) and lactoperoxidase-(LPO-)containing tablet on periodontal condition. Seventy-two individuals with chronic periodontitis were randomly assigned to take either bovine LF and LPO-containing tablets (test group, n=37) or control tablets (control group, n=35) every day for 12 weeks. Periodontal parameters and levels of subgingival plaque bacteria, human and bovine LF, and endotoxin in gingival crevicular fluid (GCF) were evaluated at baseline, 1 week, 4 weeks, and 12 weeks. Significant differences were observed in GCF levels of bovine LF between the test and control groups throughout the study (P<.05). However, clinical and bacteriological parameter values proved comparable between the two groups at 1 week to 12 weeks. Therefore, the effect of oral administration of LF and LPO-containing tablets might be weak on periodontal and bacteriological profile in this study.http://dx.doi.org/10.1155/2011/405139
spellingShingle Eiju Shimizu
Tetsuo Kobayashi
Hiroyuki Wakabayashi
Koji Yamauchi
Keiji Iwatsuki
Hiromasa Yoshie
Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
International Journal of Dentistry
title Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
title_full Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
title_fullStr Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
title_full_unstemmed Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
title_short Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
title_sort effects of orally administered lactoferrin and lactoperoxidase containing tablets on clinical and bacteriological profiles in chronic periodontitis patients
url http://dx.doi.org/10.1155/2011/405139
work_keys_str_mv AT eijushimizu effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients
AT tetsuokobayashi effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients
AT hiroyukiwakabayashi effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients
AT kojiyamauchi effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients
AT keijiiwatsuki effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients
AT hiromasayoshie effectsoforallyadministeredlactoferrinandlactoperoxidasecontainingtabletsonclinicalandbacteriologicalprofilesinchronicperiodontitispatients